Industry experts disagree with NPPA’s remark on FDCs
Experts say it is beyond the jurisdiction of NPPA
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
COVID-19 vaccine over 90 per cent effective: Pfizer
Pfizer and BioNTech said they have so far found no serious safety concerns and expect to seek US authorisation this month for…
Wellness Forever raises Rs 1.3 bn from Allana Group, Adar Poonawalla
The company aims to add over 150 more stores in the next year and 1000 retail outlets in the next three years
Bridge Biotherapeutics, Boehringer Ingelheim cancel agreement to develop BBT-877 for idiopathic…
Under the License Agreement, Bridge Biotherapeutics will regain all rights to BBT-877
Alembic Pharma gets USFDA tentative nod for Palbociclib Capsules
It is indicated for breast cancer treatment
Lupin’s Somerset facility gets 13 observations post US FDA inspection
The company does not believe that this will have an impact on disruption of supplies or the existing revenues from operations of…
Pre-existing antibodies may protect some people against COVID-19: Study
Researchers found that some people, notably children, have antibodies reactive to the novel coronavirus SARS-CoV-2 in their blood,…
Trial in Britain to assess aspirin as potential COVID-19 drug
The scientists behind the RECOVERY trial, which is looking into a range of potential treatments for COVID-19, said it would…
AIOCD writes to Ratan Tata asking not to venture into e-pharmacy space
Previously, the association has written to the heads of Amazon, Flipkart and Reliance
Rethink, Reapply and Reboot
Ankit Goyal, Healthcare and Lifesciences Practice Leader India, Heidrick & Struggles, enlarges on the changes in work trends…